In order to assess the clinical and pathologic significance of the immunologic characterization of human malignant lymphomas, biopsy tissues are obtained from patients referred to the Clinical Center for treatment and/or diagnosis. Biopsies are obtained with patient permission prior to therapy and processed in the Hematopathology Section. Paraffin blocks from biopsies performed outside the NIH are obtained for immunophenotypic characterization. The neoplastic cells are characterized as to their origin from T cells, B cells, or histiocytes, and in addition can be identified as belonging to specific developmental and functional subpopulations. Immunophenotypic data are correlated with histologic and clinical findings, with the goal of defining distinctive clinicopathologic entities. The relevance of immunophenotype as correlated with response to therapy is explored. Immunophenotypic and morphologic data are correlated with molecular and cytogenetic findings, to define the pathogenesis of disease entities. This information is used to define new clinicopathologic entities, and to further refine the definition of currently recognized diseases. It is also used as a basis for immunotherapy, either alone or in concert with conventional chemotherapy and radiotherapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC000550-16
Application #
2464419
Study Section
Special Emphasis Panel (LP)
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Shao, Haipeng; Xi, Liqiang; Raffeld, Mark et al. (2010) Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression. Am J Surg Pathol 34:1425-35
Valera, Alexandra; Balagué, Olga; Colomo, Luis et al. (2010) IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol 34:1686-94
Dunleavy, Kieron; Pittaluga, Stefania; Czuczman, Myron S et al. (2009) Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 113:6069-76
Leich, Ellen; Salaverria, Itziar; Bea, Silvia et al. (2009) Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood 114:826-34
Ouansafi, Ihsane; Bell, Stephen; Jaffe, Elaine S (2009) Adrenal Hodgkin lymphoma. Br J Haematol :
Ritchie, David; Piekarz, Richard L; Blombery, Piers et al. (2009) Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report. Haematologica 94:1618-22
Choi, William W L; Weisenburger, Dennis D; Greiner, Timothy C et al. (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15:5494-502
Cohen, J I; Kimura, H; Nakamura, S et al. (2009) Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 20:1472-82
Calvo, Katherine R; Dabir, Bhavana; Kovach, Alexandra et al. (2008) IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood 112:3818-26
Hisada, Michie; Chen, Bingshu E; Jaffe, Elaine S et al. (2007) Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst 99:215-22

Showing the most recent 10 out of 90 publications